Brevetti EPO No.3781132 2024.03.20
Brevetti EPO
(10) Registration Number and Date
2024000215 2024.06.06
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2024/000215 2019.04.15
(40) Publication Number and Date
SM /T/2024/000215 2024.06.06
(30) Priority Details
US 201862658175 P
2018.04.16
(51) IPC Classes
(72) Inventor
(IT) STEVENS, Timothy, D. : c/o Bristol-Myers Squibb Company Route 206 & Province Line Road, Princeton, NJ 08543-4000, US
(IT) BADAWY, Sherif, Ibrahim, Farag : c/o Bristol-Myers Squibb Company Route 206 & Province Line Road, Princeton, NJ 08543-4000, US
(IT) KUNTZ, Daniel : c/o Bristol-Myers Squibb Company Route 206 & Province Line Road, Princeton, NJ 08543-4000, US
(IT) WAYBRANT, Brett : c/o Bristol-Myers Squibb Company Route 206 & Province Line Road, Princeton, NJ 08543-4000, US
(74) Representative Name
(IT) SANTORO, Tiziana : Via 28 Luglio, 187, 47893 Borgo Maggiore RSM, SM
(54) Title
(IT) FORMULAZIONI DI APIXABAN
(EN) APIXABAN FORMULATIONS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2024.07.10
Event NameDateStatus
Filing2019.04.15Filed
Brevetto EPO concesso2024.06.06Published
Ricevuta pagamento annualita 62024.06.10Payed
Ricevuta pagamento annualita 72025.03.28Payed